Bank Of New York Mellon Corp Madrigal Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $2.51 Million - $12.7 Million	42,971 New	42,971 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $254,878 - $334,578	4,208 Added 11.53%	40,702 $2.65 Million
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $21,300 - $36,773	367 Added 1.02%	36,494 $2.61 Million
Q1 2022 May 11, 2022	BUY	$55.89 - $101.89 $77,295 - $140,913	1,383 Added 3.98%	36,127 $3.55 Million
Q4 2021 Feb 11, 2022	SELL	$72.34 - $95.09 $720,000 - $946,430	-9,953 Reduced 22.27%	34,744 $2.95 Million
Q3 2021 Nov 12, 2021	BUY	$78.35 - $105.02 $382,896 - $513,232	4,887 Added 12.28%	44,697 $3.57 Million
Q2 2021 Aug 11, 2021	BUY	$97.2 - $137.59 $484,347 - $685,610	4,983 Added 14.31%	39,810 $3.88 Million
Q1 2021 May 13, 2021	SELL	$108.54 - $125.2 $73,698 - $85,010	-679 Reduced 1.91%	34,827 $4.07 Million
Q4 2020 Feb 09, 2021	SELL	$110.06 - $133.7 $78,582 - $95,461	-714 Reduced 1.97%	35,506 $3.95 Million
Q3 2020 Nov 12, 2020	SELL	$99.78 - $124.21 $82,418 - $102,597	-826 Reduced 2.23%	36,220 $4.3 Million
Q2 2020 Aug 12, 2020	BUY	$60.13 - $125.71 $71,133 - $148,714	1,183 Added 3.3%	37,046 $4.2 Million
Q1 2020 May 06, 2020	BUY	$66.76 - $93.49 $112,757 - $157,904	1,689 Added 4.94%	35,863 $2.39 Million
Q4 2019 Feb 14, 2020	BUY	$84.28 - $118.5 $141,506 - $198,961	1,679 Added 5.17%	34,174 $3.11 Million
Q3 2019 Nov 07, 2019	BUY	$84.4 - $106.53 $30,215 - $38,137	358 Added 1.11%	32,495 $2.8 Million
Q2 2019 Aug 12, 2019	BUY	$91.13 - $142.5 $123,481 - $193,087	1,355 Added 4.4%	32,137 $3.37 Million
Q1 2019 May 14, 2019	SELL	$103.48 - $143.84 $3,414 - $4,746	-33 Reduced 0.11%	30,782 $3.86 Million
Q4 2018 Feb 11, 2019	SELL	$94.77 - $215.54 $632,115 - $1.44 Million	-6,670 Reduced 17.79%	30,815 $3.47 Million
Q3 2018 Nov 09, 2018	BUY	$207.3 - $300.31 $611,535 - $885,914	2,950 Added 8.54%	37,485 $0
Q2 2018 Aug 06, 2018	BUY	$101.55 - $313.9 $343,949 - $1.06 Million	3,387 Added 10.87%	34,535 $9.66 Million
Q1 2018 May 15, 2018	BUY	$93.35 - $149.04 $25,204 - $40,240	270 Added 0.87%	31,148 $3.64 Million
Q4 2017 Feb 09, 2018	BUY	$39.35 - $97.37 $1.22 Million - $3.01 Million	30,878	30,878 $2.83 Million

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

Janus Henderson Group PLC London, X0

2.48M
Shares

$778 Million
0.28% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

2.04M
Shares

$641 Million
29.57% of portfolio
Avoro Capital Advisors LLC New York, NY

2.03M
Shares

$637 Million
6.48% of portfolio
Rtw Investments, LP New York, NY

1.99M
Shares

$626 Million
6.74% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$620 Million
4.49% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.37B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account